$Evidence of a role of tumor necrosis factor alpha in refractory asthma.$

Evidence of a role of tumor necrosis factor alpha in refractory asthma.

BACKGROUND: The development of tumor necrosis factor alpha (TNF-alpha) antagonists has made it feasible to investigate the role of this cytokine in refractory asthma. METHODS: We measured markers of TNF-alpha activity on peripheral-blood monocytes in 10 patients with refractory asthma, 10 patients...

Full description

Bibliographic Details
Main Authors:	Berry, M, Hargadon, B, Shelley, M, Parker, D, Shaw, D, Green, R, Bradding, P, Brightling, C, Wardlaw, A, Pavord, I
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.
by: Berry, M, et al.
Published: (2005)

Antagonism of tumour necrosis factor alpha in refractory asthma.
by: Berry, M, et al.
Published: (2008)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
by: Haldar, P, et al.
Published: (2009)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
by: Bilocca, D, et al.
Published: (2017)

Mepolizumab in refractory eosinophilic asthma.
by: Pavord, I, et al.
Published: (2010)

Tumor necrosis factor-alpha: a promising therapeutic target for asthma?
by: Heffler, E, et al.
Published: (2007)

TNF-alpha in asthma.
by: Berry, M, et al.
Published: (2007)

Body mass and fat mass in refractory asthma: an observational 1 year follow-up study.
by: Bafadhel, M, et al.
Published: (2010)

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
by: Shaw, D, et al.
Published: (2007)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
by: Green, R, et al.
Published: (2002)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
by: Berry, M, et al.
Published: (2007)

New insights into the role of the mast cell in asthma.
by: Brightling, C, et al.
Published: (2003)

Exacerbations of severe asthma in patients treated with mepolizumab
by: Shrimanker, R, et al.
Published: (2018)

The significance of eosinophilic airway inflammation in asthma
by: Pavord, I, et al.
Published: (2002)

New insights into the relationship between airway inflammation and asthma.
by: Wardlaw, A, et al.
Published: (2002)

Cluster analysis and clinical asthma phenotypes.
by: Haldar, P, et al.
Published: (2008)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
by: Berry, M, et al.
Published: (2005)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
by: Brightling, C, et al.
Published: (2003)

The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.
by: Shaw, D, et al.
Published: (2007)

Mast-cell infiltration of airway smooth muscle in asthma.
by: Brightling, C, et al.
Published: (2002)

Chapter 11. Mast cell localization within the airway smooth muscle: Relationship to airway hyperresponsiveness and other asthma phenotypes
by: Wardlaw, A, et al.
Published: (2004)

A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma.
by: Shaw, D, et al.
Published: (2012)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
by: Haldar, P, et al.
Published: (2014)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
by: Berry, M, et al.
Published: (2004)

Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
by: Saha, S, et al.
Published: (2008)

The relationship between clinical outcomes and medication adherence in difficult-to-control asthma.
by: Murphy, A, et al.
Published: (2012)

Cough and asthma.
by: Berry, M, et al.
Published: (2003)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
by: Haldar, P, et al.
Published: (2014)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
by: Haldar, P, et al.
Published: (2014)

Management of asthma in adults: current therapy and future directions.
by: Green, R, et al.
Published: (2003)

Evidence for the efficacy and safety of anti- interleukin-5 treatment in the management of refractory eosinophilic asthma
by: Xue, L, et al.
Published: (2015)

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.
by: Fairs, A, et al.
Published: (2010)

Refractoriness to inhaled sodium metabisulphite in subjects with mild asthma.
by: Pavord, I, et al.
Published: (1994)

Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.
by: Brightling, C, et al.
Published: (2003)

Eosinophils in asthma and other allergic diseases.
by: Wardlaw, A, et al.
Published: (2000)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
by: Brightling, C, et al.
Published: (2002)

Qualitative analysis of high-resolution CT scans in severe asthma.
by: Gupta, S, et al.
Published: (2009)

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).
by: Agbetile, J, et al.
Published: (2014)

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study)
by: Agbetile, J, et al.
Published: (2014)

Cross refractoriness between sodium metabisulphite and exercise induced asthma.
by: Pavord, I, et al.
Published: (1994)